Terms: = Leukemia AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729
86 results:
1. LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.
Yang YL; Qian ZY; Zhao Y; Chen XL; Huang QY; Guo YJ; Sun LN; Wang YQ
Biomed Chromatogr; 2023 Dec; 37(12):e5738. PubMed ID: 37724003
[TBL] [Abstract] [Full Text] [Related]
2. Simultaneous quantification of venetoclax and voriconazole in human plasma by UHPLC-MS/MS and its application in acute myeloid leukemia patients.
Gao P; Zhang W; Fang X; Leng B; Zhang Y; Liu X; Wang X; Guo N
J Pharm Biomed Anal; 2023 Apr; 227():115279. PubMed ID: 36739719
[TBL] [Abstract] [Full Text] [Related]
3. Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type.
Mehta RS; Marin D; Alousi A; Kanakry CG; Champlin RE; Rezvani K; Shpall EJ; Page K; Gadalla SM; Weisdorf D; Kebriaei P
Blood Adv; 2023 Apr; 7(8):1594-1603. PubMed ID: 36630564
[TBL] [Abstract] [Full Text] [Related]
4. Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.
Ureña-Bailén G; Dobrowolski JM; Hou Y; Dirlam A; Roig-Merino A; Schleicher S; Atar D; Seitz C; Feucht J; Antony JS; Mohammadian Gol T; Handgretinger R; Mezger M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361619
[TBL] [Abstract] [Full Text] [Related]
5. Five EMT-Related Gene Signatures Predict Acute Myeloid leukemia Patient Outcome.
Qi J; Yan J; Idrees M; Almutairi SM; Rasheed RA; Hussein UA; Abdel-Maksoud MA; Wang R; Huang J; Huang C; Wang N; Huang D; Hui Y; Li C
Dis Markers; 2022; 2022():7826393. PubMed ID: 36246561
[TBL] [Abstract] [Full Text] [Related]
6. [Predictive Value of Acute Phase Proteins on the Prognosis of Patients with Acute Myeloid leukemia].
Wu XJ; Wang YQ; Yang XY; Lin XS; Qiu MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1086-1093. PubMed ID: 35981366
[TBL] [Abstract] [Full Text] [Related]
7. An association between cancer type and delirium incidence in Japanese elderly patients: A retrospective longitudinal study.
Yamato K; Ikeda A; Endo M; Filomeno R; Kiyohara K; Inada K; Nishimura K; Tanigawa T
Cancer Med; 2023 Feb; 12(3):2407-2416. PubMed ID: 35880545
[TBL] [Abstract] [Full Text] [Related]
8. Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies.
Strand AM; Alexander BD; Sarpong E; Wong JR; Engemann A; Rizzieri D; Wu Y; Johnson MD
Mycoses; 2022 Nov; 65(11):1050-1060. PubMed ID: 35816393
[TBL] [Abstract] [Full Text] [Related]
9. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Jo T; Arai Y; Kondo T; Mizuno S; Hirabayashi S; Inamoto Y; Doki N; Fukuda T; Ozawa Y; Katayama Y; Kanda Y; Fukushima K; Matsuoka KI; Takada S; Sawa M; Ashida T; Onizuka M; Ichinohe T; Atsuta Y; Kanda J; Yanada M
Cytotherapy; 2022 Oct; 24(10):1013-1025. PubMed ID: 35729020
[TBL] [Abstract] [Full Text] [Related]
10. Correlation of the transcription factors
Zhang Y; Zeng X; Zha X; Lai J; Tan G; Chen S; Yu X; Li Y; Xu L
Hematology; 2022 Dec; 27(1):523-529. PubMed ID: 35544467
[TBL] [Abstract] [Full Text] [Related]
11. Quantification of Venetoclax for Therapeutic Drug Monitoring in Chinese Acute Myeloid leukemia Patients by a Validated UPLC-MS/MS Method.
Yang X; Mei C; He X; He L; Lu X; Tong H; Lou Y
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268708
[TBL] [Abstract] [Full Text] [Related]
12. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
[TBL] [Abstract] [Full Text] [Related]
13. Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous leukemia in Adults.
Metheny L; Callander NS; Hall AC; Zhang MJ; Bo-Subait K; Wang HL; Agrawal V; Al-Homsi AS; Assal A; Bacher U; Beitinjaneh A; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Cairo M; Cerny J; DeFilipp Z; Perez MAD; Freytes CO; Ganguly S; Grunwald MR; Hashmi S; Hildebrandt GC; Inamoto Y; Kanakry CG; Kharfan-Dabaja MA; Lazarus HM; Lee JW; Nathan S; Nishihori T; Olsson RF; Ringdén O; Rizzieri D; Savani BN; Savoie ML; Seo S; van der Poel M; Verdonck LF; Wagner JL; Yared JA; Hourigan CS; Kebriaei P; Litzow M; Sandmaier BM; Saber W; Weisdorf D; de Lima M
Transplant Cell Ther; 2021 Nov; 27(11):923.e1-923.e12. PubMed ID: 34428556
[TBL] [Abstract] [Full Text] [Related]
14. Association of novel stop-gained leukaemia inhibitory factor receptor gene (rs121912501) variant, leukaemia inhibitory factor and ovarian steroids with unexplained infertility among Pakistani women.
Ali R; Iqbal MUN; Rehman R; Khan TA
Int J Clin Pract; 2021 Jul; 75(7):e14245. PubMed ID: 33914392
[TBL] [Abstract] [Full Text] [Related]
15. Starch-based magnetic nanocomposite for targeted delivery of hydrophilic bioactives as anticancer strategy.
Sousa ACC; Romo AIB; Almeida RR; Silva ACC; Fechine LMU; Brito DHA; Freire RM; Pinheiro DP; Silva LMR; Pessoa ODL; Denardin JC; Pessoa C; Ricardo NMPS
Carbohydr Polym; 2021 Jul; 264():118017. PubMed ID: 33910740
[TBL] [Abstract] [Full Text] [Related]
16. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
[TBL] [Abstract] [Full Text] [Related]
17.
Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
[TBL] [Abstract] [Full Text] [Related]
18. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
19. [Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].
Zhang ML; Chen WS; Han B
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):637-642. PubMed ID: 32942816
[No Abstract] [Full Text] [Related]
20. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid leukemia Patients.
Cortés AA; Olmedillas S; Serrano-López J; Lainez-González D; Castaño T; Iñiguez R; Lopez-Lorenzo JL; García A; Atance M; Sánchez RNS; Lopez CB; Arranz MG; Sillero PL; Alonso-Dominguez JM
Mol Diagn Ther; 2020 Oct; 24(5):593-600. PubMed ID: 32875515
[TBL] [Abstract] [Full Text] [Related]
[Next]
